ExploreConditionAlloxan Diabetes
Condition

Alloxan Diabetes

Also known as: Alloxan Diabetes Diabetes, Alloxan diabetes incident diabetes
33 findings 2 papers 15 related entities View in graph →

Related entities

interventions
outcomes
populations
studys

Findings (50)

None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

The strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both

Effect: null; non-significant in both ILS and metformin groups

Size: non-significant in both ILS and metformin groups
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models

Papers (2)